These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 24193321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
    Nellenbach K, Guzzetta NA, Brown AC.
    J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M, Fenger-Eriksen C, Wierup P, Greisen J, Ingerslev J, Hjortdal V, Sørensen B.
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E, Heitmeier S, Laux V, Buchmüller A.
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
    Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH.
    Anesth Analg; 2008 Mar; 106(3):732-8, table of contents. PubMed ID: 18292410
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
    Ingerslev J, Holm M, Christiansen K, Knudsen L, Négrier C.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
    [Abstract] [Full Text] [Related]

  • 18. Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
    Le Saché F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, Emmerich J, Samama CM.
    Br J Anaesth; 2012 Apr; 108(4):586-93. PubMed ID: 22258204
    [Abstract] [Full Text] [Related]

  • 19. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery.
    Mehringer SL, Klick Z, Bain J, McNeely EB, Subramanian S, Pass LJ, Drinkwater D, Reddy VS.
    Ann Pharmacother; 2018 Jun; 52(6):533-537. PubMed ID: 29332420
    [Abstract] [Full Text] [Related]

  • 20. Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.
    Kaspereit F, Hoffmann S, Pragst I, Dickneite G.
    Br J Anaesth; 2010 Nov; 105(5):576-82. PubMed ID: 20716565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.